EQUITY RESEA RC H Ageas August 2015

Company results 5 August 2015

Ageas Buy (mai ntai ned) Capitalising on reassurance on cash flows

Price (04/08/15) They message on capital and cash flow are very reassuring; dividends and €38.50 holding expenses are well covered from up-streamed dividends of the Target price (12-mth) business units. We stick to our €1.65 DPS for FY15F, but a surprise seems €43.00 (previously €41.00) possible. The message on Asia continues to remain positive. We have Forecast total return 16.0% increased the value of Asian operations in our SOTP: TP raised to €43.0. BUY.

Solid 2Q15 result: The net profit show ed a beat at €306m versus our forecast at Insurance €280m (incl. a one-off gain of €100m from Taiping Life). In net profit w as ahead of our Belgium forecast at €102m (INGF 92m), driven by non-life. Asia recorded another strong quarter, w ith Bloomberg: AGS BB reported profit at €154m; excluding the one-off gain in China, still a beat at c.€54m (INGF Reuters: AGES.BR €48m and 1Q: €58m). Adjusted for FX Asian earnings grow th remains very sound. Non-life

profit show ed a clear beat (€74m vs INGF €49m) driven by Belgium and CEU. The 2Q15 Share data combined ratio w as a strong 94%, adjusted for prior year reserve releases 99.5% (in line).

Av g daily volume (3-mth) 641,246 Guidance w as unchanged for a COR below 97% FY15. Free f loat (%) 94.5 New versus old forecasts (€m) Market cap (€m) 8,078.9 Net debt (1F, €m) FY15F FY16F F Y17F Enterprise v alue (1F, €m) New Old %ch New Old %ch New Old %ch Div idend yield (1F, %) 4.3 Belgium 384 374 3 399 385 4 407 393 4 Source: Company data, ING estimates UK 69 75 -8 80 83 -4 91 93 -3 CE 99 91 9 95 78 22 100 82 21 Share price performance Asia 317 215 48 246 242 1 288 276 4 General* (63) 14 -547 (56) (38) 47 (56) (38) 47 40 Net profit 811 771 5 763 749 2 829 806 3 o/w Insurance profit 869 755 15 819 788 4 885 848 4 35 EPS (€) 3.72 3.52 6 3.50 3.43 2 3.81 3.69 3 30 DPS (€) 1.65 1.65 0 1.80 1.80 0 1.90 1.90 0 25 Source: ING estimates *) we have not included book gains on purchases of CASHES as timing is difficult 20

15 Capital and cash flows reassuring messages: 1H15 cash flow from operations w ere €381m 10 (incl. €15m from RPI) and from capital restructuring €125m or €506m. Our previous forecast was 7/10 7/11 7/12 7/13 7/14 7/15 total dividend upstream for FY15 of €527m; we now see €594m. Management repeated that the Price full year dividend is based on a pay-out of 40-50% of insurance profit, including the €100m BEL 20 (rebased) exceptional gain in Asia. For now we keep our DPS forecast for FY15 unchanged at €1.65 (FY14: Source: ING €1.55), but this could surprise on the upside. Ageas announced a new share buyback of €250m (INGF €200-250m) in line w ith the previous programme. Ageas did not comment on speculation about the potential sale of Hong Kong (De Tijd: value indicated c.€1bn). We w ould regard a potential sale as a positive at this valuation level. Ageas is setting up an internal company based in the (invested €100m), as the location chosen is for tax reasons (DTAs). Retention of premiums w ill thus rise over time and w e believe there are S2 benefits.

Cash and free cash flow yield (Єm)

2014 2015F 2016F 2017F

Holding f ree cash flow yield (%) 8.2 8.3 9.5 10.5 Holding free cash flow yield (%) ex net cash 10.2 10.4 11.9 13.2 Share buy back program 250 250 250 250 Total cash & liquid assets* 1,912 1,775 1,567 1,315 % market capitalization 22 20 18 15 Source: ING estimates *) we assume €100m cash-out related to CASHES over 2015-16F

BUY r ating maintained, TP raised to €43.0 (from €41.0). In our view the results show that the Asian angle that w e have highlighted before remains overlooked in the investment case. In our SOTP w e have raised valuation of Asian activities from €2.2bn to €2.9bn. If w e would value Albert Ploegh, CEFA the Asian activities at transactions multiples w e reach over €5bn. Moreover, the cash flow Amsterdam +31 20 563 8748 [email protected] profile remains supportive for capital returns to shareholders, also demonstrated by the new

share buyback programme of €250m (c.3% of market capitalisation).

research.ing.com SEE THE DISCLOSURES APPENDIX FOR IMPORTANT DISCLOSURES & ANALYST CERTIFICATION1

Ageas August 2015

Valuation: TP set at €43.0 (from €41 .0) (€m) Financials

P/B (x) PER (x) Fair PS Year end Dec (€m) 2012 2013 2014 2015F 2016F 2017F 1H15 2016F value (€) Income statement Belgium (100%) 0.8 9.7 5,151 24.7 o/w lif e 0.8 10.3 4,252 20.4 Gross written premiums 7,111 6,498 6,631 6,893 7,221 7,568 o/w non lif e 1.0 7.7 899 4.3 Property & casualty 4,362 3,971 4,103 4,268 4,439 4,616 Put option AG insurance (25%) (1,286) (6.2) Lif e 2,749 2,527 2,528 2,624 2,782 2,952 Belgium v aluation 0.8 9.7 3,865 18.6 Segmental operating profits UK 0.6 10.0 798 3.8 Lif e 779 734 766 946 943 1,005 Continental Europe 0.9 9.0 855 4.1 Property & casualty 368 319 236 377 383 397 Asia 1.0 11.7 2,860 13.7 0 0 0 0 0 0 Operating entities 0.9 10.2 8,378 40.2 Other businesses 147 (85) (260) (60) (56) (56) General account 0.7 919 4.4 Net interest 0 0 0 0 0 0 Total 0.8 12.3 9,296 44.7 Corporate expenses/consd (26) 11 50 (19) (8) 2 Litigation risk (500) (2.4) Operating profit 1,268 980 792 1,244 1,262 1,348 Restricted cash 130 0.6 Net capital gains (losses) 0 0 0 0 0 0 Target Price (€) 0.8 11.8 8,926 43.0 Non-op income (expense) 0 0 0 0 0 0 Pre-tax profit 1,268 980 792 1,244 1,262 1,348 Source: ING estimates Tax (339) (241) (137) (250) (296) (309) Minorities (186) (169) (180) (183) (204) (210) Implied PER (ex Taiping stake – China) Other post-tax items 0 0 0 0 0 0 Net profit 743 570 475 811 763 829 Market cap Ageas 8,078 IFRS net operating profit 743 570 475 811 763 829 Minus holding co cash (equivalents) 1,721 Value operating entities 6,358 EEV income statement Minus v alue 25% stake Taiping Life 1,777 Lif e new business value 69 120 89 92 95 98 Remaining v alue operating entities 4,581 EEV operating prof it 236 326 266 357 350 343 Net prof it insurance (2015 ex Taiping) 705 EEV net prof it 1,557 678 597 357 350 343 Implied PER (x) 6.5 Opening embedded v alue 4,008 5,542 5,629 5,691 5,513 5,328 Source: ING estimates Closing embedded value 5,565 5,787 5,691 5,513 5,328 5,136

Balance sheet Company profile Opening shareholders’ funds 7,760 9,749 8,698 8,391 9,493 9,725 Ageas offers international insurance services under its Closing shareholders’ funds 9,749 8,698 8,391 9,493 9,725 9,868 segments, Life (70% of net insurance profit in 2014) Ordinary equity 9,799 8,525 10,223 11,325 11,478 11,665 Equity 9,799 8,525 10,223 11,325 11,478 11,665 and Non-Life (30%), as well as disability and medical Minorities 872 805 688 594 594 594 services to individuals and groups. The company Total equity 10,671 9,330 10,912 11,919 12,072 12,259 operates in Belgium, the UK, Continental Europe and Total debt 4,884 4,335 4,570 4,570 4,570 4,570 Asia. Belgium, its largest market, accounted for c.50% Total capital 15,554 13,665 15,481 16,489 16,642 16,829 of net insurance profit, while Asia contributed almost Performance & returns 25%, and the UK and Continental Europe contributed the remainder. APE (new business) mgn (%) 11.2 22.6 18.4 100.6 96.0 91.1 PVNBP margin (%) 1.2 2.4 2.0 2.0 2.0 1.9 P&C combined ratio (%) 99.1 98.6 99.6 98.4 96.9 96.9 Risks IFRS net op profit growth (%) n/a -23.4 -16.6 70.7 -5.9 8.7 BV growth (%) 26.3 -13.0 19.9 10.8 1.4 1.6 General risks relate to financial markets: for example, Embedded v alue growth (%) 51.0 4.0 -1.7 -3.1 -3.4 -3.6 lower equity markets, prolonged low interest rates. Lif e ROEV (%) 5.9 5.9 4.7 6.3 6.4 6.4 Reported ROE (%) 8.5 6.2 5.1 7.5 6.7 7.2 Legacy issues that remain and can cause quarterly Solv ency ratio (%) 203.8 207.1 205.5 217.6 220.2 222.8 volatility in earnings and shareholders’ equity are: (1) Gearing (%) 31.4 31.7 29.5 27.7 27.5 27.2 the written put option on the 25%+1 share of AG Insurance to BNP Paribas and (2) RPN(I) Valuation liability, which reflects the net present value of the Price/embedded value (x) 1.7 1.5 1.5 1.5 1.6 1.6 expected future interest payments related to a liability Price/book (x) 0.96 1.0 0.81 0.74 0.73 0.72 Price/tangible book (x) 1.1 1.2 0.95 0.85 0.84 0.82 vis-à-vis BNP Paribas Fortis and to the Belgium State PER (IFRS net op EPS) (x) 12.3 15.5 18.1 10.3 11.0 10.1 for its granted guarantee. Litigation risks. There are Div idend yield (%) 3.1 3.6 4.0 4.3 4.7 4.9 several legal proceedings and investigations pending that could result in claims. We deduct from our Per share data valuation €500m to reflect litigation risk, but this could IFRS net operating EPS (€) 3.13 2.49 2.13 3.72 3.50 3.81 prove to be too optimistic estimate. IFRS net op EPS growth (%) n/a -20.4 -14.5 74.9 -5.9 8.7 Div idend per share (€) 1.20 1.40 1.55 1.65 1.80 1.90

EEV per share (€) 22.89 25.30 26.50 25.32 24.47 23.59 BV/share (€) 40.31 37.28 47.60 52.01 52.71 53.57 Tangible BV/share (€) 34.14 31.10 40.67 45.17 45.88 46.73 Source: Company data, ING estimates

2 Ageas August 2015

Disclosures Appendix ANALYST CERTIFICATION The analyst(s) w ho prepared this report hereby certifies that the view s expressed in this report accurately reflect his/her personal view s about the subject securities or issuers and no part of his/her compensation w as, is, or w ill be directly or indirectly related to the inclusion of specific recommendations or view s in this report. IMPORTANT DISCLOSURES For disclosures on companies other than the subject companies of this report visit our disclosures page at http://research.ing.com or write to The Compliance Department, ING Financial Markets LLC, 1325 Avenue of the Americas, New York, USA, 10019. US regulatory disclosures • The follow ing subject company/ies of this report are or have been a client of ING Financial Markets LLC or an affiliate w ithin the last 12 months and have received services: Ageas. Valuation & risks: For details of the methodologies used to determine our price targets and risks related to the achievement of these targets refer to main body of report and/or the most recent equity company report at http://research.ing.com. Research analyst(s): The research analyst(s) for this report may not be registered/qualified as a research analyst w ith the NYSE and/or NASD. The research analyst(s) for this report may not be an associated person of ING Financial Markets LLC and therefore may not be subject to Rule 2711 restrictions on communications w ith a subject company, public appearances and trading securities held by the research analyst’s account. European regulatory disclosures • The follow ing subject company/ies of this report are or have been party to an investment banking agreement w ith one or more members of ING Group over the last 12 months: Ageas. The remuneration of research analysts is not tied to specific investment banking transactions performed by ING Group although it is based in part on overall revenues, to w hich investment banking contribute. Financial interests: One of more members of ING Group may hold financial interests in the companies covered in this report other than those disclosed above. Securities prices: Prices are taken as of the previous day’s close on the home market unless otherw ise stated. Job titles. The functional job title of the person/s responsible for the recommendations contained in this report is equity research analyst unless otherw ise stated. Corporate titles may differ from functional job titles. Conflicts of interest policy. ING manages conflicts of interest arising as a result of the preparation and publication of research through its use of internal databases, notifications by the relevant employees and Chinese w alls as monitored by ING Compliance. For further details see our research policies page at http://research.ing.com. Other disclosures Target prices, w here included, are based on reasonable assumptions supported by objective data. Unless otherw ise stated, neither historic share price performance data nor ING projections on potential share price performance reflect the impact of commissions, fees and charges. Past performance is not indicative of future results. Forecasts are not a reliable indicator of future performance. FOREIGN AFFILIATES DISCLOSURES Each ING legal entity w hich produces research is a subsidiary, branch or affiliate of ING Bank N.V. See back page for the addresses and primary securities regulator for each of these entities.

RATING DISTRIBUTION (as of end 2Q15) RATING DEFINITIONS

Equity cov erage Investment Banking clients* Buy: Forecast 12-mth absolute total return greater than +15% Buy 47% 53% Hold: Forecast 12-mth absolute total return of +15% to -5% Hold 48% 62% Sell: Forecast 12-mth absolute total return less than -5% Sell 5% 13% 100% Total return: forecast share price appreciation to target price plus forecast annual dividend. Price volatility and our preference for not changing recommendations too * Percentage of companies in each rating category that are Investment Banking frequently means forecast returns may fall outside of the above ranges at times. clients of ING Financial Markets LLC or an affiliate.

3 Ageas August 2015

PRICE & RATINGS HISTORY TO 02/07/15: AGEAS (AGES.BR)

45

40

35

30

25

20 B 15 2/7/12 2/10/12 2/1/13 2/4/13 2/7/13 2/10/13 2/1/14 2/4/14 2/7/14 2/10/14 2/1/15 2/4/15 2/7/15

Price Target price

B = Buy; H = Hold; S = Sell; NR = Not Rated; R = Restricted Chart shows ING coverage: current analyst may or may not have covered the stock for the entire period shown Where ING coverage is longer than three years, chart shows recommendation current at start of the share price history Source: ING

4

Ageas August 2015

AM ST ERDAM BRUSS ELS NEW YORK SINGAPORE Tel: 31 20 563 8758 Tel: 32 2 547 7534 Tel: 44 20 7767 1000 Tel: 1 646 424 6000 Tel: 65 6535 3688

Bratislava Frankfurt c Madrid Paris Sofia Tel: 421 2 5934 6111 Tel: 49 69 75936 519 Tel: 34 91 789 8880 Tel: 33 1 56 39 32 84 Tel: 359 2 917 6400

Bucharest Geneva Manila Prague Taipei Tel: 40 21 222 1600 Tel: 41 22 592 3079 Tel: 63 2 479 8888 Tel: 420 257 474 111 Tel: 886 2 8729 7600

Budapest Hong Kong Mexico City Sao Paulo Tok yo Tel: 36 1 235 8800 Tel: 852 2848 8488 Tel: 52 55 5258 2000 Tel: 55 11 4504 6000 Tel: 81 3 3217 0301 Buenos Aires Istanbul Milan Seoul Warsaw Tel: 54 11 4310 4700 Tel: 90 212 335 1000 Tel: 39 02 55226 2468 Tel: 82 2 317 1800 Tel: 48 22 820 5018 Dublin Kiev Moscow Shanghai Tel: 353 1 638 4000 Tel: 380 44 230 3030 Tel: 7 495 755 5400 Tel: 86 21 2020 2000

Research offices: legal entity/address/primary securities regulator Amsterdam ING Bank NV, Foppingadreef 7, Amsterdam, Netherlands, 1102BD. Netherlands Authority for the Financial Markets ING Belgium SA/NV, Av enue Marnix 24, Brussels, Belgium, B-1000. and Market Authority (FSMA) Bucharest ING Bank NV Amsterdam - Bucharest Branch, 48 Iancu de Hunedoara Bd, 011745, Bucharest 1, Romania. Financial Supervisory Authority, Romanian National Bank Budapest ING Bank NV Hungary Branch, Dozsa Gy orgy ut 84\B, H - 1068 Budapest, Hungary . National Bank of Hungary Frankfurt ING-DiBa AG, Theodor-Heuss-Allee 2, 60486 Frankf urt, Germany. Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) Istanbul ING Bank AS, ING Bank Headquarters, Resitpasa Mahallesi Eski Buy ukdere Cad. No.8, 34467 Sariy er, Istanbul, Turkey . Capital Markets Board London ING Bank NV London Branch, 60 London Wall, London EC2M 5TQ, . Financial Conduct Authority Manila ING Bank NV Manila Branch, 20/F Tower One, Ay ala Triangle, Ay ala Av enue, 1226 Makati City , Philippines. Philippine Securities and Exchange Commission Milan ING Bank NV Milano, Via Arbe, 49, Milano, Italy , 20125. Commissione Nazionale per le Società e la Borsa Moscow ING Bank (Eurasia) JSC, 36, Krasnoproletarskay a ulitsa, 127473, Moscow, Russia. The Central Bank of Russia New York ING Financial Markets LLC, 1325 Av enue of the Americas, New York, United States,10019. Securities and Exchange Commission Prague ING Bank NV, Prague Branch, Českomorav ská 2420/15, Prague 9, Czech Republic. Czech National Bank Singapore ING Bank NV Singapore Branch, 19/F Republic Plaza, 9 Raf f les Place, #19-02, Singapore, 048619. Monetary Authority of Singapore Warsaw ING Securities SA, Ul. Pulawska 2, Warsaw, Poland, 02-566. Polish Financial Supervision Authority

Disclaimer This report has been prepared on behalf of ING (being for this purpose the commercial banking business of ING Bank NV and certain of its subsidiary companies) solely for the information of its clients. ING forms part of ING Group (being for this purpose ING Groep NV and its subsidiary and af f iliated companies). It is not inv estment advice or an offer or solicitation f or the purchase or sale of any f inancial instrument. While reasonable care has been taken to ensure that the inf ormation contained herein is not untrue or misleading at the time of publication, ING makes no representation that it is accurate or complete. The inf ormation contained herein is subject to change without notice. ING Group and any of its officers, employees, related and discretionary accounts may , to the extent not disclosed above and to the extent permitted by law, have long or short positions or may otherwise be interested in any transactions or inv estments (including deriv atives) referred to in this report. In addition, ING Group may provide banking, insurance or asset management services for, or solicit such business from, any company referred to in this report. Neither ING Group nor any of its officers or employees accepts any liability for any direct or consequential loss arising from any use of this report or its contents. Copyright and database rights protection exists in this report and it may not be reproduced, distributed or published by any person f or any purpose without the prior express consent of ING. All rights are reserv ed. Any inv estments ref erred to herein may inv olv e signif icant risk, are not necessarily available in all jurisdictions, may be illiquid and may not be suitable for all investors. The value of, or income from, any investments ref erred to herein may fluctuate and/or be affected by changes in exchange rates. Past performance is not indicative of future results. Investors should make their own inv estigations and inv estment decisions without relying on this report. Only investors with sufficient knowledge and experience in financial matters to evaluate the merits and risks should consider an investment in any issuer or market discussed herein and other persons should not take any action on the basis of this report. Clients should contact analysts at, and execute transactions through, an ING entity in their home jurisdiction unless gov erning law permits otherwise. Additional inf ormation is av ailable on request. Country-sp ecific disclosures: EEA: This report constitutes “investment research” for the purposes of the Markets in Financial Instruments Directive and as such contains an objective or independent explanation of the matters contained herein. Any recommendations cont ained in this report must not be relied on as inv estment advice based on the recipient’s personal circumstances. If f urther clarif ication is required on words or phrases used in this report, the recipient is recommended to seek independent legal or financial advice. Hong Kong: This report is distributed in Hong Kong by ING Bank N.V., Hong Kong Branch which is licensed by the Securities and Futures Commission of Hong Kong under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (“SFO”). This document does not constitute a solicitation or an offer of securities or an invitation to the public within the meaning of the SFO. This report is to be circulated only to “professional investors” as def ined in the SFO. Italy: This report is issued in Italy only to persons described in Article No. 58 of Consob Regulation No. 16190. Singapore: This document is provided in Singapore by or through ING Bank N.V., Singapore Branch and is prov ided only to accredited inv estors, expert investors and institutional investors, as defined in Section 4A of the Securities and Futures Act, Cap. 289. If y ou are an accredited inv estor or expert inv estor, please be informed that in ING’s dealings with you, ING is relying on the following exemptions to the Financial Advisers Act, Cap. 110 (“FAA”): (1) the exemption in Regulation 33 of the Financial Advisers Regulations (“FAR”), which exempts ING from comply ing with Section 25 of the FAA on disclosure of product inf ormation to clients; (2) the exemption set out in Regulation 34 of the FAR, which exempts ING f rom comply ing with Section 27 of the FAA on recommendations; and (3) the exemption set out in Regulation 35 of the FAR, which exempts ING from comply ing with Section 36 of the FAA on disclosure of certain interests in securities. United Kingdom: This report is issued in the United Kingdom by ING Bank N.V., London Branch only to persons described in Articles 19, 47 and 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and is not intended to be distributed, directly or indirectly , to any other class of persons (including private investors). United States: Any person wishing to discuss this report or effect transactions in any security discussed herein should contact ING Financial Markets LLC, which is a member of the NYSE, FINRA and SIPC and part of ING, and which has accepted responsibility for the distribution of this report in the United States under applicable requirements. The distribution of this report in other jurisdictions may be restricted by law or regulation and persons into whose possession this document comes should inf orm themselv es about, and observ e, any such restrictions.

EQ Additional information is available on request

5